Oxygenta Pharmaceutical Limited (BOM:524636)

Oxygenta Pharmaceutical Revenue

Oxygenta Pharmaceutical had revenue of 143.02M INR in the quarter ending September 30, 2025, with 2.12% growth. This brings the company's revenue in the last twelve months to 1.12B, up 141.99% year-over-year. In the fiscal year ending March 31, 2025, Oxygenta Pharmaceutical had annual revenue of 1.09B with 175.71% growth.

• Revenue (ttm): 1.12B
• Revenue Growth: +141.99%
• P/S Ratio: 1.91
• Revenue / Employee: 6.41M
• Employees: 175
• Market Cap: 2.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1.09B	696.57M	175.71%
Mar 31, 2024	396.42M	86.55M	27.93%
Mar 31, 2023	309.87M	-295.37M	-48.80%
Mar 31, 2022	605.25M	84.98M	16.33%
Mar 31, 2021	520.27M	383.01M	279.03%